HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yoji Ishizu Selected Research
Yoji Ishizu Research Topics
Disease
26
Hepatocellular Carcinoma (Hepatoma)
04/2022 - 01/2015
14
Neoplasms (Cancer)
11/2021 - 12/2014
12
Fibrosis (Cirrhosis)
04/2022 - 06/2012
10
Chronic Hepatitis C
12/2021 - 04/2010
9
Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 06/2012
8
Inflammation (Inflammations)
04/2022 - 01/2016
7
Infections
01/2021 - 08/2016
6
Hepatitis C
03/2021 - 08/2016
5
Non-alcoholic Fatty Liver Disease
04/2022 - 09/2015
5
Hemorrhage
10/2021 - 02/2019
5
Hepatitis B
01/2021 - 10/2013
4
Liver Diseases (Liver Disease)
01/2022 - 03/2019
4
Hepatitis
01/2021 - 01/2016
3
Hepatic Encephalopathy
03/2022 - 03/2019
3
Alcoholic Fatty Liver
11/2021 - 09/2017
3
Disease Progression
10/2021 - 05/2016
3
Fever (Fevers)
06/2020 - 01/2016
3
Thrombosis (Thrombus)
04/2020 - 01/2016
2
Varicose Veins (Varicose Vein)
12/2022 - 10/2021
2
Diarrhea
03/2022 - 02/2020
2
Hemophilia A (Haemophilia)
01/2022 - 01/2021
2
Chronic Hepatitis B
01/2021 - 01/2015
2
Hypersplenism (Anemia, Splenic)
01/2020 - 01/2013
2
Autoimmune Hepatitis
05/2016 - 01/2016
2
Autoimmune Pancreatitis
05/2016 - 01/2016
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2022
1
Portal Hypertension
10/2021
1
Obesity
01/2021
1
Vitelliform Macular Dystrophy
04/2020
1
Hand-Foot Syndrome
02/2020
1
Virus Diseases (Viral Diseases)
01/2020
1
Insulin Resistance
01/2020
1
Thrombocytopenia (Thrombopenia)
01/2020
1
Obstructive Jaundice (Cholestatic Jaundice)
01/2020
1
Hypersensitivity (Allergy)
10/2019
1
Drug Hypersensitivity (Drug Allergy)
10/2019
Drug/Important Bio-Agent (IBA)
11
Antiviral Agents (Antivirals)
IBA
01/2022 - 08/2016
10
Sorafenib (BAY 43-9006)
FDA Link
06/2020 - 01/2015
6
Choline (Choline Chloride)
IBA
04/2022 - 09/2015
5
lenvatinib
IBA
03/2022 - 03/2020
4
Bilirubin
IBA
08/2021 - 02/2018
4
Interferons
IBA
02/2018 - 06/2012
4
Ribavirin (Virazole)
FDA Link
Generic
02/2018 - 04/2010
4
daclatasvir
IBA
01/2018 - 08/2016
4
asunaprevir
IBA
01/2018 - 08/2016
3
Immune Checkpoint Inhibitors
IBA
02/2022 - 06/2020
3
Therapeutic Uses
IBA
11/2021 - 01/2019
3
Pemetrexed (MTA)
FDA Link
08/2021 - 03/2021
3
Branched-Chain Amino Acids
IBA
01/2020 - 01/2017
3
regorafenib
IBA
10/2019 - 01/2018
3
Immunoglobulins (Immunoglobulin)
IBA
05/2016 - 10/2014
2
Estrogens (Estrogen)
FDA Link
04/2022 - 09/2015
2
Amino Acids
FDA Link
01/2022 - 01/2021
2
Albumins
IBA
08/2021 - 03/2021
2
Carbon Tetrachloride (Tetrachloromethane)
IBA
01/2021 - 09/2017
2
Hepatitis B e Antigens
IBA
01/2021 - 01/2015
2
Cytidine Triphosphate (CTP)
IBA
09/2020 - 07/2020
2
Ramucirumab
IBA
04/2020 - 09/2019
2
alpha-Fetoproteins (alpha-Fetoprotein)
IBA
04/2020 - 01/2015
2
telomerase RNA (bTR)
IBA
01/2020 - 01/2020
2
Zinc
IBA
01/2020 - 01/2020
2
Tyrosine (L-Tyrosine)
FDA Link
01/2020 - 01/2020
2
Pharmaceutical Preparations
IBA
10/2019 - 12/2014
2
Serum Albumin
IBA
02/2018 - 01/2018
2
gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)
IBA
02/2018 - 01/2018
2
Antigens
IBA
02/2018 - 10/2013
2
Proteins (Proteins, Gene)
FDA Link
09/2017 - 10/2014
2
Hepatitis B Surface Antigens (HBsAg)
FDA Link
11/2016 - 01/2015
2
Immunoglobulin G (IgG)
IBA
05/2016 - 01/2016
1
Sclerosing Solutions (Sclerosing Agents)
IBA
12/2022
1
astaxanthine (astaxanthin)
IBA
04/2022
1
Osteoprotegerin
IBA
04/2022
1
Butyrates (Butyrate)
IBA
03/2022
1
Rifaximin (L 105)
FDA Link
03/2022
1
Diethylnitrosamine (N-Nitrosodiethylamine)
IBA
11/2021
1
Emulsions
IBA
11/2021
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
10/2021
1
Conditioned Culture Media
IBA
01/2021
1
Indicators and Reagents (Reagents)
IBA
01/2021
1
Isoleucine (L-Isoleucine)
FDA Link
01/2021
1
Leucine (L-Leucine)
FDA Link
01/2021
1
Blood Coagulation Factors (Coagulation Factor)
IBA
01/2021
1
CTLA-4 Antigen
IBA
06/2020
1
Ipilimumab
IBA
06/2020
1
Volatile Fatty Acids
IBA
02/2020
1
Biomarkers (Surrogate Marker)
IBA
01/2020
1
Thrombopoietin (c-mpl Ligand)
IBA
01/2020
1
Hyaluronic Acid (Hyaluronan)
IBA
01/2020
1
Tyrosine Kinase Inhibitors
IBA
10/2019
1
Vitamin K 2 (Vitamin K2)
IBA
03/2019
Therapy/Procedure
19
Therapeutics
12/2022 - 04/2010
8
Liver Transplantation
01/2021 - 01/2013
3
Ligation
10/2021 - 01/2016
1
Sclerotherapy
12/2022
1
Time-to-Treatment
01/2022
1
Molecular Targeted Therapy
08/2021
1
Aftercare (After-Treatment)
03/2021
1
Surgical Portasystemic Shunt (Portosystemic Shunt)
03/2021
1
Intravenous Administration
01/2021
1
Radiofrequency Ablation
01/2021